Signup for Newsletter:

Copyright © Ennovent GmbH.

All rights reserved.

About This Project

Ennovent helped to scale agro and healthcare companies from Samridhi Fund’s portfolio, that were providing sustainable benefits to targeted low-income states in India.


Ennovent worked with the fund to shortlist two of its portfolio enterprises, Gramco Infratech and Kanungo Institute of Diabetes Specialities, for tailored mentoring assistance and diagnosed their growth challenges.


Ennovent engaged mentors and experts to help Gramco address issues related to infrastructure, distribution and financing partnerships in its value chain. Kanungo was assisted to address human resource challenges pertaining to its marketing and IT capacity, and the training of its hospital staff.





Food, Health

Dear Friends,


Thank you for your interest in Ennovent! We closed down Ennovent’s operations at the end of March 2024.


We had been deliberating about continuing our work in the changing overall market and impact space during the last year. The decision to close came after careful consideration of major policy shifts, changing funding priorities and market challenges that have significantly affected our business model.


Reflecting on our journey since 2008, we are filled with great pride in the legacy Ennovent leaves behind. We have been a catalyst for more than 250 ventures across 40 countries through our involvement in 90 projects. Our mission has always been to promote businesses with sustainable solutions for low-income markets, a goal that we pursued with unwavering commitment. As we move forward, our team members remain dedicated to pursuing lasting sustainable impact through their future endeavours.


We deeply appreciate your support and patronage over the years.


Warm regards,
Team Ennovent